enfortumab vedotin,pembrolizumab
merck,astellas,seagen
['bladder', ' vedo', 'enfortumab', 'urothelial', 'pembro']
pembrolizumab/enfortumab vedotin combo hits high response rate in urothelial cancer #esmo22 #urology #urologist #bladdercancer 
Expert clinical analysis. Practice advice. Policy perspectives.